Treatment-shortening regimens for tuberculosis: updates and future priorities

In the past 2 years, remarkable advances have been made in shortening tuberculosis (TB) treatment. In particular, four clinical trials (Study 31/A5349, Nix-TB, ZeNix and TB-PRACTECAL) have provided evidence of the efficacy of regimens based on new and repurposed drugs: the 4-month regimen for drug-s...

Descripción completa

Detalles Bibliográficos
Autores principales: Saluzzo, Francesca, Adepoju, Victor Abiola, Duarte, Raquel, Lange, Christoph, Phillips, Patrick P.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567072/
https://www.ncbi.nlm.nih.gov/pubmed/37830101
http://dx.doi.org/10.1183/20734735.0028-2023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567072/
https://www.ncbi.nlm.nih.gov/pubmed/37830101
http://dx.doi.org/10.1183/20734735.0028-2023

Ejemplares similares